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Ancient grainsNon-celiac gluten sensitivity (NCGS) is still an undefined syndrome whose triggering mechanisms remain
unsettled. This study aimed to clarify how cultured peripheral blood mononucleated cells (PBMC)
obtained from NCGS patients responded to contact with wheat proteins. Results demonstrated that
wheat protein induced an overactivation of the proinflammatory chemokine CXCL10 in PBMC from NCGS
patients, and that the overactivation level depends on the cereal source fromwhich proteins are obtained.
CXCL10 is able to decrease the transepithelial resistance of monolayers of normal colonocytes (NCM 460)
by diminishing the mRNA expression of cadherin-1 (CDH1) and tight junction protein 2 (TJP2), two pri-
mary components of the tight junction strands. Thus, CXCL10 overactivation is one of the mechanisms
triggered by wheat proteins in PBMC obtained from NCGS patients. This mechanism is activated to a
greater extent by proteins from modern with respect to those extracted from ancient wheat genotypes.
 2014 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The consumption of wheat-based products is estimated to be
very high in most Western countries (i.e. Europe, United States)
and in continuous increase in Eastern countries as a consequence
of a shift toward a Western lifestyle (Rubio-Tapia et al., 2009;
Van den Broeck et al., 2010). Nowadays, most of the wheat prod-
ucts we consume are made frommodern wheat varieties bred after
the ‘‘Green Revolution” (in the 1970s). The introduction of dwarf
genes led to the development of short straw lines with substantial
gains in productivity and technological quality. The variation in
dough rheology and bread-making performance among wheat
varieties is largely determined by the differences in protein content
and quality composition, depending on specific gliadins and high
molecular weight glutenin subunits (Sliwinski, Kolster, Prins, &van Vliet, 2004). Not dwarf wheat genotypes, bred after the ‘‘Green
Revolution” are defined as old. Generally, old wheat varieties have
weaker rheological properties than the modern ones, as demon-
strated by alveographic analyses (Guarda, Padovan, & Delogu,
2004). In recent years, scientists have shown increasing interest
in investigating nutritional differences among wheat varieties,
old genotypes and ancestors due to their diverse nutrient and phy-
tochemical composition. Research studies concerned dietary fiber
content (Marotti et al., 2012), phenolics and terpenoid composition
(Di Silvestro et al., 2012; Shewry et al., 2011), but strong efforts
recently focused on the study of gluten proteins, a major cause of
celiac disease (CD) and gluten-related pathologies (Carroccio
et al., 2011; Molberg et al., 2005; van den Broeck et al., 2010).
From an evolutionary point of view, gluten proteins were
absent from the diet of hunter gatherers (Schnorr et al., 2014)
and were introduced in human nutrition only about 10,000 years
ago. This may explain the lack of a complete adaptation of humans
to the ingestion of gluten proteins. Nevertheless, different studies
demonstrate that the prevalence of CD has increased over the last
60 years (Lohi et al., 2007; Rubio-Tapia et al., 2009). Moreover, the
increasing number of patients worldwide who are sensitive to
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has contributed to the identification of a new gluten-related syn-
drome known as non-celiac gluten sensitivity (NCGS) (Volta,
Caio, Tovoli, & De Giorgio, 2013). Double-blind placebo-controlled
trials have confirmed that gluten proteins are involved in the
development of this syndrome (Biesiekierski et al., 2011;
Carroccio et al., 2012). The molecular mechanisms of NCGS remain
for the most part unknown, even if it is widely accepted that the
innate immune system plays a major role in the onset of NCGS
(Catassi et al., 2013; Sapone et al., 2011). Even if the prevalence
of NCGS in the western population is still debated, it seems clear
that in recent years it has rapidly increased in adults (Sapone
et al., 2012; Volta et al., 2014) and in children (Francavilla et al.,
2014). Recently, modern wheat strains have been implicated in
NCGS (de Lorgeril & Salen, 2014).
The present study evaluated the in vitro chemokine response of
PMBC from NCGS patients to different cereals (including modern
and ancient wheat genotypes) aiming to identify a possible marker
for NCGS.2. Materials and methods
2.1. Cereal samples
The investigated cereal samples consisted of a modern common
wheat (Triticumaestivum L.) ‘‘Manitoba” variety, a modern durum
wheat (Triticumturgidum spp. durumDesf. Husn.) ‘‘Claudio” variety,
an old Italian durum wheat (Triticumturgidum spp. durumDesf.
Husn.) ‘‘SenatoreCappelli” variety, an accession of KAMUT khora-
san wheat (Triticumturgidum spp. turanicumJakubz), and a sample
of rice (Oryzasativa L.) gluten-free flour as a negative control.
KAMUT is a registered trademark of KAMUT International Ltd.
and KAMUT Enterprises of Europe bvba. Manitoba and rice samples
were purchased at local supermarkets. The flours of Claudio, Sena-
toreCappelli and KAMUT khorasan were obtained from the wheat
germplasm of the Department of Agricultural Science of the Uni-
versity of Bologna (Italy) and were organically grown. Grains were
milled using a stone mill (100% flour extraction).2.2. Protein extraction
Proteins were extracted using the procedure described by
Osborne (1907) and subsequently modified by Lookhart and Bean
(1995) and van den Broeck et al. (2009). Proteins were extracted
from three seed replicates for each accession. Briefly, 100 mg of
flour was treated with 500 ll of distilled water (30 min,
160 rpm) vortexing for 1 min at 10-min intervals for the extraction
of albumins. Samples were than centrifuged at 7000 rpm for 5 min
and the supernatant collected. Albumin extraction was repeated
with 400 ll of distilled water (10 min, 160 rpm), centrifuged and
the second extract collected. The pellet was treated with 400 ll
of NaCl 0.5 M (30 min, 160 rpm) vortexing for 1 min at 10-min
intervals for the extraction of globulins. After centrifugation
(3500 rpm, 5 min), the supernatant was collected and the globulin
extraction repeated (400 ll of NaCl 0.5 M; 10 min, 160 rpm) to
obtain the second globulin extract. Subsequently, the remaining
pellet was used for the extraction of prolamins. Four hundred
microliter of 50% (v/v) aqueous isopropanol were added to the test
tube to allow the solubilization of gliadins (30 min, 160 rpm). After
centrifugation (3500 rpm, 15 min), the first gliadin extract was col-
lected and the extraction was repeated (10 min, 160 rpm). Glute-
nins were extracted using a solution of 50% (v/v) aqueous
isopropanol containing 1% (w/v) DL-dithiothreitol for 30 min at
160 rpm and centrifuged at 10,000 rpm for 10 min. The superna-
tant was collected and the extraction repeated once. For thein vitro tests, all the extracts were pooled to obtain a total protein
extract for each cereal variety.
2.3. Protein electrophoretic profiles (SDS–PAGE)
The protein profiles of the cereal samples investigated were
obtained using the BoltMini Gel Tank (InvitrogenTM, Life Technol-
ogies) compatible with the Bolt Bis–Tris Plus precast gels (10%).
Electrophoretic patterns were obtained from three replicates for
each cultivar. For the electrophoresis analysis the first superna-
tants of albumins, globulins and glutenins, and the second super-
natant of gliadins were used. Extracts (30 ll) were diluted with
15 ll BoltTM LDS sample buffer, 6 ll BoltTM reducing agent, 9 ll dis-
tilled water and denatured at 70 C for 10 min. The BoltTM MOPS
SDS running buffer was used for the run at 165 V (25 min). The
protein patterns were compared with the Mark12TM unstained stan-
dard (2.5–200 KDa) for albumins and globulins, and the SeeBlue
Plus2 pre-stained standard (4–250 KDa) for gliadins and glutenins.
The protein profiles were elaborated as presence/absence of the
observed subunits for each sample.
2.4. Protein content and quantification of allergenic epitopes
The total protein content was measured using the Kjeldahl pro-
cedure (N  5.7) (AACC, 1983). Wheat flours were tested for the
content of gluten allergenic epitopes using the RIDASCREENGlia-
din competitive ELISA (R-Biopharm AG, Darmstadt, Germany).
Flour samples were treated with the RIDA Extraction Solution
(R7099) to enable the solubilization of the gliadin fraction. The test
is based on the antigen–antibody reaction between gluten epitopes
and the R5 antibody. The absorbance values were obtained at
450 nm using a microplate reader (Multiskan EX 1.1 MTX Lab
Systems, Virginia, USA). Results were compared with those of
gliadin standard (5–80 ppb) and elaborated using the software
RIDASOFT Win.net (R-Biopharm AG, Darmstadt, Germany).
Epitope contents were expressed as percentage of total protein
amount.
2.5. Patients
The study population included 48 NCGS patients (females 39,
males 9, median age 41 years, range 20–67 years), diagnosed as
having NCGS after a thorough evaluation in the tertiary referral
centers of the SpedaliCivili (Brescia, Italy) and S.Orsola-Malpighi
Hospital (Bologna, Italy). All these patients complained of one or
more gastrointestinal (bloating, abdominal pain, diarrhea/consti-
pation, nausea, epigastric pain, gastro-esopagheal reflux, aphthous
stomatitis) and extra-intestinal (tiredness, headache, joint/muscle
pain, arm numbness, ‘foggy mind’, dermatitis/skin rash, anxiety,
depression, anemia) symptoms/manifestations with an early onset
(a few hours or days) after gluten ingestion. As extensively stated
in the literature (Catassi et al., 2013; Sapone et al., 2012), a funda-
mental prerequisite for NCGS diagnosis is the exclusion of both CD
and wheat allergy (WA) on a gluten-containing diet. CD was ruled
out in all 48 enrolled NCGS patients by negativity for anti-tissue
transglutaminase (anti-tTG) and anti-endomysial antibodies
(EmA) and the absence of villous atrophy in the duodenal biopsy,
whereas WA was excluded by the negativity for specific IgE anti-
bodies to wheat and/or skin prick tests. NCGS patients were put
on a gluten-free diet obtaining a complete remission or a signifi-
cant improvement of both gastrointestinal and extra-intestinal
symptoms, thus confirming the clinical suspicion of NCGS. Thirty
healthy volunteers, age- and sex-matched with the NCGS group,
were enrolled among students and medical staff of the two referral
centers (Bologna and Brescia). A blood sample was obtained from
both NCGS patients and healthy volunteers. Before undergoing
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free to gluten-containing diet for 6 weeks. The study was approved
by the SpedaliCivili of Brescia and St.Orsola-Malpighi Hospital
Independent Institutional Ethical Committees. Patients and
healthy donors gave their written informed consent.
2.6. Isolation and culture of PBMC
Blood samples obtained from NCGS enrolled patients and
healthy volunteers were collected in EDTA-containing vacuum
tubes and kept under agitation on a roller mixer at room temper-
ature for 4 h. PBMC separation was obtained using the kit-MateTM
Sep 15 (STEMCELL Technologies, Vancouver, BC, Canada), following
the manufacturer’s instructions. PBMCs were resuspended in 1 ml
of complete RPMI-1640 (Life Technologies, CA, USA), supple-
mented with 25 mM HEPES and antibiotics (penicillin and strepto-
mycin). After careful resuspension, 4  105 cells were seeded in
each well of a 24-well plate. 40 lg of protein extracts of selected
flours were resuspended in 200 ll of RPMI-1640 and added to
PBMC cultures. Plates were incubated for 12 h at 37 C and 5%
CO2 (Forma Series II Water Jacketed CO2 Incubator), under mild
shaking.
2.7. Determination of secreted CXCL10
After incubation, the well contents were transferred into eppen-
dorf tubes and supernatant was collected after centrifugation
(1000g for 15 min at RT) and subjected to cytokine/chemokine
determination using Luminex MAP technology as previously
described (Brigotti et al., 2013). Cytokine and chemokine levels
were first determined using a multiplexed 27-plex human bead
immunoassay kit (Bio-Rad, CA, USA). Then, a single plex for CXCL10
was used. Microsphere magnetic beads coated with monoclonal
antibodies against cytokines and chemokines were added to the
wells. After incubation for 30 min, the wells were washed and
biotinylated secondary antibodies were added. After incubation
for another 30 min, beads were washed and then incubated for
10 min with streptavidin-PE conjugated to the fluorescent protein,
phycoerythrin (streptavidin/phycoerythrin). After washing, the
beads (a minimum of 100 per analyte) were analyzed in the
BioPlex 200 instrument (BioRad). Sample concentrations were esti-
mated from the standard curve using a fifth-order polynomial
equation and expressed as pg/ml after adjusting for the dilution
factor (Bio-Plex Manager software 5.0). Samples below the detec-
tion limit of the assay were recorded as zero, while samples above
the upper limit of quantification of the standard curves were
assigned the highest value of the curve. The intra-assay CV aver-
aged 12%. This method is covered by patents owned by Alma Mater
Studiorum, University of Bologna (WO 2014/037858; PCT/IB2013/
058148).
2.8. Colonocyte cell culture and transepithelial electrical resistance
(TEER) determination
Normal mucosa NCM-460 cells, kindly provided by Dr. Antonio
Strillacci (University of Bologna, Italy) were grown in DMEM cul-
ture medium supplemented with 10% fetal bovine serum (FBS),
100 U1 ml penicillin and 100 g1 ml streptomycin at 37 C in a
humidified atmosphere of 95%, with 5% CO2. For maximum viabil-
ity, NCM460 cells were subcultured in fresh and spent growth
medium in at a 1:1 ratio. All cell culture reagents were provided
by Invitrogen (Milan, Italy). Differentiation of NCM460 cells to
polarized monolayers was performed modifying the method
reported by Dalpiaz et al. (2012). Briefly, after two passages, con-
fluent NCM460 cells were seeded at a density of 25  104 cells/
insert in the growth medium (fresh and spent medium 1:1) on24-well Millicell inserts (Millipore, Milan, Italy) consisting of
1.0 lm pore size polyethylene terephthalate filter membranes,
whose surface was 0.33 cm2. Filters were presoaked for 24 h with
fresh culture medium, and then the upper compartment (apical,
A) received 0.2 ml of cells, whereas the lower (basolateral, B)
received 1.25 ml of the cell-free growth medium. Half the volume
of culture medium was replaced every 2 days with fresh medium
to each of the apical and basolateral compartments. The integrity
of the cell monolayers was monitored by measuring transepithelial
electrical resistance (TEER) by means of a voltmeter (Millicell-ERS;
Millipore, Milan, Italy). The measured resistance value was multi-
plied by the area of the filter to obtain an absolute value of TEER,
expressed as X cm2. The background resistance of blank inserts
not plated with cells was around 35X cm2 and was deducted from
each value. The homogeneity and integrity of the cell monolayer
were also monitored by phase contrast microscopy. Based on these
parameters, cell monolayers reached confluence and epithelial
polarization after 7 days and monolayers with a TEER stable value
around 200X cm2 were used. Cell monolayers were treated with
concentrations ranging from 0.01 to 10 ng/ml of CXCL10 (R&D Sys-
tems, Inc., Minneapolis, MN, USA) reconstituted at 100 lg1 ml in
sterile PBS containing 0.1% BSA and added to serum-free medium
of the apical or the basolateral side. Corresponding amounts of
BSA were also added to untreated cells. The integrity of the conflu-
ent polarized monolayers was verified by measuring TEER at differ-
ent time intervals. 10 ng/ml human IL-1b (R&D Systems, Inc.,
Minneapolis, MN, USA) were also added to the apical or basolateral
side of the appropriate inserts as positive control.
2.9. RNA extraction and real-time PCR
Total RNA from CXCL10-treated NCM460 cells was extracted
using Trizol reagent (Life Technologies, CA, USA) according to
the manufacturer’s instructions. Extracted RNA samples were trea-
ted with DNase I to remove any genomic DNA contamination using
DNA-free kit (Ambion, USA) and reverse-transcripted using ran-
dom hexamerprimers (Fermentas, Canada). E-cadherin, Zonulin-
1, 2, 3 and b-actin mRNA levels were analyzed by real-time PCR
using SYBR Select Master Mix (Life Technologies, CA, USA) and
StepOne PlusTM system (Applied Biosystems, CA, USA) according
to the manufacturer’s instructions. The melting curve data were
collected to check PCR specificity. Each cDNA sample was analyzed
in triplicate. Target mRNA levels were normalized against b-actin
mRNA and relative expressions were calculated using the 22DCt
formula. Cadherin-1 primer pairs: 50-AAGAAGGAGGCGGAGAA-
GAG-30 and 50-ACACGAGCAGAGAATCATAAGG-30 (228 bp product);
tight junctions protein 1 primer pairs: 50-CCAGAGACCAACAAG-
GAACC-30 and 50-CCGACATCATTGCCACCAG-30 (185 bp product);
tight junctions protein 2 primer pairs: 50-CACGCCGAGCAGA
TTGTC-30 and 50-GTCTCCCTTCTTGAACCTTACC-30 (226 bp product);
tight junctions protein 3 primer pairs: 50-CTCTTCACAGCCAC-
CATCC-30 and 50-CCGTCCGTCTCGTAGTCG-30 (200 bp product);
b-actin primer pairs: 50-ACCAACTGGGACGACATGGAG-30 and
50-GTGGTGGTGAAGCTGTAGCC-30 (207 bp product).
2.10. Statistical analyses
One-way analysis of variance (ANOVA) was carried out to assess
the significance of the differences among cereal samples for the
protein and epitopes content, to assess the differences among
CXCL10 secretion and to assess the differences among mRNA rela-
tive expression. Tukey’s Honestly Significant Difference test was
used to determine differences between means at P < 0.05. Principal
component analysis (PCA) was performed on the standardized
matrix of presence/absence of each protein electrophoretic band
to compare the protein profiles of cereal sources. Two-way ANOVA
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differences of TEER variations, at P < 0.05 and at P < 0.01. All statis-
tical analyses were conducted using Statistica 6.0 software (Stat-
Soft, Tulsa, OK, USA). GraphPad Prism 6 software (GraphPad
Software, Inc., CA, USA) was also used to analyze differences in
CXCL10 secretion.K K C C M M S S  K K C C M M S S  
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MW3. Results
3.1. Protein and allergenic epitope content of cereal sources
The investigated cereal sources showed a broad variation in the
total protein amount (Table 1). The lowest protein level was found
for the rice flour (5.9 ± 0.1 g/100 g). Among the wheat samples, the
commercial Manitoba flour had the lowest protein amount equal
to 11.8 ± 0.1 g/100 g. Organically grown old wheat varieties
KAMUT khorasan flour and SenatoreCappelli had the highest pro-
tein content, with mean values of 16.8 ± 0.1 and 16.4 ± 0.2 g/100 g,
respectively. The modern durumwheat genotype Claudio semolina
showed a lower protein amount of 12.4 ± 0.2 g/100 g. The gluten
extracts of cereal samples were also tested for the presence of
T-cell stimulatory peptides using the RIDASCREENGliadin com-
petitive ELISA. The immunoassay is based on the use of R5 mono-
clonal antibody which recognizes specific sequences (QQPFP,
QQQFP, LQPFP, QLPFP) occurring in gliadins (van den Broeck
et al., 2009). Epitope content is reported in Table 1 and expressed
as mg/kg of flour and as percentage of total protein. No epitopes
were detected in the rice flour sample, confirming the ‘‘gluten-fee”
label of the commercially purchased product. Considering the con-
centration of epitopes expressed in mg/kg, the old durum wheat
variety SenatoreCappelli showed the highest amount
(28.2 ± 1.2 mg/kg), while the other cereal samples had values rang-
ing from 21.3 ± 0.3 to 22.3 ± 0.2 mg/kg. van den Broeck et al. (2009)
reported that the epitope content of different wheat varieties ran-
ged from 8.26 to 21.30 mg/kg and therefore our results align with
the highest limit of that study. Since the cereal samples showed a
broad variation in total protein content, the percentage of epitopes
in the total protein can provide information on the quality compo-
sition of the protein fractions. Results showed that Claudio, Mani-
toba and SenatoreCappelli had similar percentage values (0.017–
0.019%) while KAMUT khorasan wheat showed the lowest per-
centage (0.013%) suggesting that, although it was the richest in
proteins, KAMUT khorasan flour had a slight but statistically sig-
nificant lower epitope composition. This may be related to a lower
concentration of gliadin proteins carrying allergenic epitopes
among the total protein pattern.K K C C M M S S  K K C C M M S S
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MW3.2. Protein profiles of cereal sources
The protein profiles of the investigated wheat samples were
characterized using SDS–PAGE electrophoresis. All the protein frac-
tions (albumins, globulins, gliadins, glutenins) were analyzed andTable 1
Protein and gluten epitope content (±standard deviation) of the cereal flours
investigated.
Proteins Epitopes
g/100g mg/kg % on tot. proteins
Claudio 12.4 ± 0.2 (c) 21.3 ± 0.3 (b) 0.017 ± 0.001 (a)
Kamut 16.8 ± 0.1 (a) 22.3 ± 0.2 (b) 0.013 ± 0.001 (b)
Manitoba 11.8 ± 0.1 (d) 22.0 ± 1.0 (b) 0.019 ± 0.001 (a)
SenatoreCappelli 16.4 ± 0.2 (b) 28.2 ± 1.2 (a) 0.017 ± 0.001 (a)
Rice 5.9 ± 0.1 (e) N.d. N.d.
Abbreviations: N.d., not detected.the patterns compared to determine the differences among cereal
samples (Fig. 1). The matrix of presence/absence of each electro-
phoretic band detected was elaborated using PCA, and the distribu-
tion of the cases as a function of the first and second principal
components is shown in Fig. 2 (explaining 66.84% and 19.24% of
the total variability, respectively). Multivariate analysis of the elec-
trophoretic data allowed a description of the differences detected
among the protein profiles of the wheat genotypes. Manitoba flour
had the most divergent protein profile and it was projected along
the negative arm of the first component (PC1), at a great distance
from the other cases located in the positive arm of PC1 (Fig. 2).
The divergence of this sample was expected as it is the only hexa-
ploid genotype among tetraploid varieties. The tetraploid wheats
(Claudio, KAMUT khorasan wheat, SenatoreCappelli) shared sim-
ilar protein profiles for the albumin and globulin fractions, while
Manitoba had 4 albumins (between 24 and 37 kDa) and 5 globulins
(31–60 kDa) that were not found in the tetraploid genotypes. The
tetraploid wheats also differed for the gliadin profile and had 6
subunits of x-, ab- and c-gliadins (with molecular weight ranging
from 44 to 65 kDa) not detected in the other samples. The
KAMUT khorasan sample was projected on the negative part of
the second principal component (PC2), while Claudio and Senato-
reCappelli were clustered together on the positive arm (Fig. 2).
The main differences detected among these genotypes were
related to the glutenin profiles. The KAMUT khorasan sample
lacked the high and low molecular weight glutenin subunits found
in both Claudio and SenatoreCappelli flour (i.e. 32, 68 and 91 kDa
subunits), and had 48 and 80 kDa subunits exclusively detected
on the khorasan sample.3.3. CXCL10 secreted by PBMC of NCGS patients and healthy controls
Significant differences were observed in the responses of PBMC
from healthy donors stimulated with protein extracts from flour
containing gluten compared to stimulation with rice gluten-free
flour (Fig. 3 panel A). CXCL10 secretion was significantly higher
(P < 0.01) for all four grains tested. This means that the secretion
of this pro-inflammatory cytokine is somehow stimulated by
protein extracts of cereals containing gluten. Using corn flour-188 - 
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Fig. 1. Electrophoretic patterns of the investigated wheat varieties. The protein
profiles were obtained by using SDS–PAGE electrophoresis for each protein
fractions (A, albumins; B, globulins; C, gliadins; D, glutenins). Abbreviations: K,
KAMUT khorasan wheat; C, Claudio; M, Manitoba; S, SenatoreCappelli.
Fig. 2. Score plot of the first two principal components obtained from the
electrophoretic patterns of the investigated wheat varieties. Claudio, KAMUT
khorasan wheat, Manitoba and SenatoreCappelli electrophoretic data were elabo-
rated using the matrix of presence/absence of each detected protein band in the
four protein fractions (albumins, globulins, gliadins, glutenins). PCA was carried out
with three samples for each variety. In the Cartesian plan, the mean coordinates of
each variety are shown.
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Fig. 3. CXCL10 secretion by cultured PBMC stimulated with different wheat protein
extracts. PBMC obtained from healthy donors (A) or from NCGS patients (B) were
stimulated for 24 h with total wheat protein extracts from different wheat cultivars.
The amount of secreted CXCL10, measured by using Luminex assay, is indicated as
mean ± 1SD. a, P < 0.001 vs. Manitoba group. b, P < 0.001 vs. rice group.
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results (not shown), thereby confirming that the increased CXCL10
secretion seems to be due to gluten-containing cereal proteins. The
responses of PBMC from NCGS patients stimulated with protein
extracts from flour containing gluten compared to stimulation
with gluten-free flours (rice) showed a significantly higher level
of secreted CXCL10 (P < 0.01) for all four grains tested (Fig. 3 panel
B). It is interesting that the responses of PBMC stimulated with
protein extracts from gluten-containing flours significantly
increased both in healthy controls and in NCGS patients. However,
the levels of CXCL10 secretion under stimulation by gluten-con-
taining flours were significantly higher in NCGS patients for all four
grains tested (P < 0.01). When we analyzed separately the effect ofthe modern grains from that of the ancient grains, we found that
modern dwarf varieties (Manitoba and Claudio) behave differently
from the old varieties (SenatoreCappelli and khorasan) in terms of
chemokine secretion. Analyzing the differences in terms of CXCL10
secretion stimulated by modern vs. ancient grains, we verified that
these differences were always significant, both in NCGS patients
and in healthy controls (P < 0.01). Analyzing the differences in
CXCL10 secretion stimulated by the two modern grains (Manitoba
vs. Claudio) we could not observe a significance either in healthy
controls (P > 0.33) or in NCGS patients (P > 0.17). The differences
between the two ancient grains used (SenatoreCappelli vs. khora-
san wheat) showed no significance in healthy controls (P = 0.22)
while in NCGS patients SenatoreCappelli seemed to stimulate
CXCL10 secretion to a lesser extent than khorasan wheat
(P = 0.060).
3.4. Proinflammatory chemokine decreased transepithelial electrical
resistance (TEER) in NCM460 cells
To evaluate the effect of CXCL10 on intestinal barrier function in
the in vitromodel of the normal human colon cell line NCM460, we
measured the TEER of cell cultures in Millicell systems. TEER of
NCM460 cells increased in a time-dependent manner, achieving a
plateau after 7 days, representing the establishment of tight mon-
olayers (data not shown). NCM460 cell monolayers were therefore
exposed to chemokine after barrier function was established. For
determination of mucosal or serosal effects of CXCL10, cell mono-
layers were treated for up to 54 h with concentrations ranging
from 0.01 ng/ml to 10 ng/ml of CXCL10 in the apical (mucosal) or
basolateral (serosal) side and TEER was measured over time. The
proinflammatory cytokine IL-1b (10 ng/ml) was also added on each
of the two sides of separate inserts as a positive control, since IL-1b
was previously reported to impair barrier functions in intestinal
epithelia (Al-Sadi et al., 2013). Two-way ANOVA indicated that
variations in TEER value significantly depended on cell treatment
(P < 0.0001) and sampling time (P < 0.0001). As expected, a signif-
icant decrease in TEER values in comparison to control cells was
obtained after exposure NCM460 cells in the apical (mucosal) side
to 10 ng/ml IL-1b for 24 h (P < 0.05) up to 54 h, with a maximal
effect after 48 h (P < 0.001) (Fig. 4 panel A). Further, addition of
CXCL10 (0.01–10 ng/ml) to the apical side for up to 54 h resulted
in a time- but not concentration-dependent decrease in TEER, with
a significant effect starting after 48 h of exposure and similar for all
the concentrations used when compared to the control group
(P < 0.001), but without any significant difference from the
IL-1b-induced TEER decrease at any concentration (Fig. 4 panel
A). Exposure of the NCM460 cell monolayer basolateral (serosal)
side to 10 ng/ml IL-1b induced a significant TEER decrease after
24 h (P < 0.05) reaching a maximal effect after 48 h (P < 0.001) in
comparison to the control cells (Fig. 4 panel B). CXCL10 (0.01–
10 ng/ml) added to the basolateral side (Fig. 4 panel B) induced
both a time- and concentration-dependent decrease in TEER, with
a significant effect starting at a concentration of 0.01 ng/ml and
after 48 h of exposure when compared to the control group
(P < 0.001). A broader TEER decrease against control cells
(P < 0.001) was obtained when IL-1b and CXCL10 were present in
the basolateral side, where the effects of the lower concentrations
of CXCL10 were also significantly different from the IL-1b-induced
TEER decrease.
The mechanism by which CXCL10, added in the basolateral
(serosal) side, affected TERR was analyzed by real-time PCR, evalu-
ating the expression of genes involved in tight junction formation.
The basolateral side was chosen since it is where CXCL10 could be
secreted by the intra-epithelial lymphocytes (IEL). CXCL10 deter-
mines the decreased intestinal permeability of NCM460 monolayer
via the decreased expression of cadherin-1 (CDH1) mRNA (P < 0.05
Fig. 4. Transepithelial electrical resistance (TEER) through NCM460 cells induced
by CXCL10. CXCL10 and interleukin-1b (IL-1b) were added to the apical (A) or to the
basolateral side of the Millicell insert monolayers (B). Increasing concentrations of
CXCL10 were applied to the apical side (A) or to the basolateral side (B) of NCM460
monolayers. Data are the mean ± SEM of three experiments, performed in duplicate
on individual NCM460 monolayers. *P < 0.05 and **P < 0.001 vs. control group.
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1  10 ng/ml) (Table 2), which are all part of the tight junction
complex (Lu, Ding, Lu, & Chen, 2013).4. Discussion
Although awareness of NCGS has progressively increased, this
diagnosis remains highly presumptive and based only on a clinical
evaluation since no biomarker is yet available. As there is currently
no serological test able to identify NCGS, antigliadin antibodies
have been proposed as a possible indicator, being found in aboutTable 2
Expression of tight junction genes evaluated by real time PCR. mRNA expression was evalu
the Millicell insert monolayers and normalized against b-actin mRNA. Down arrows indic
Gene Fold-change relative expression (22D
CXCL10 1 ng/ml
Mean SD
Cadherin-1 (CDH1) 0.89 0.10
Tight junctions protein 1 (TJP1) 0.94 0.08
Tight junctions protein 2 (TJP2) 0.78 0.07
Tight junctions protein 3 (TJP3) 1.04 0.0950% of NCGS patients (Carroccio et al., 2012; Sapone et al., 2012;
Volta et al., 2012), but their usefulness is limited by their very
low specificity (Volta et al., 2008). In vitro cytokine responses of
PMBCs to gluten and rice have been studied in patients with IBS
and gluten sensitivity, but this research failed to disclose a bio-
marker for NCGS (Vazquez-Roque et al., 2013). An overactive che-
mokine profile has recently been documented in the small
intestinal mucosa of patients with untreated CD (Bondar et al.,
2014), and this may explain the specific recruitment of the major
cell populations that infiltrate the epithelium and lamina propria
in CD. This finding prompted us to study the in vitro chemokine
response of PMBC from NCGS patients to different cereal sources
(including modern and ancient wheat genotypes). For this study
we chose to use four different wheat grains, two modern and
two ancient varieties, characterized by different protein profiles.
Our previous studies disclosed that under organic agricultural
management the old not dwarf wheat genotypes have the highest
ability to accumulate proteins during grain filling (Di Silvestro
et al., 2012). Although pattern analysis did not identify variety-spe-
cific protein profiles, it provided a description of variable qualita-
tive composition of each wheat grain investigated. Protein
variability may have different effects on digestibility and the
immune-stimulatory activity of cereal products in the human
body. Proteins extracted from the different flours were used undi-
gested for stimulation of PBMC. Although these proteins are sub-
jected to digestive processes in human gut, a fraction of these
proteins may reach the small intestine undigested and be assimi-
lated by transcytosis. Furthermore, in vitro methods of enzymatic
digestion introduce an important experimental variable difficult
to control, and do not guarantee comparable results with what
really happens in the human gut. The decision to use all the protein
fractions and not only the fractions containing gliadin and glutenin
is due to the possibility that other wheat proteins, such as lectins,
wheat germ agglutinin or a-amylase/trypsin inhibitors, activate
innate immune responses involved in the mechanisms of gluten
sensitivity (Dalla Pellegrina et al., 2009; Haas et al., 1999; Junker
et al., 2012). In line with this hypothesis, many investigators prefer
to use the term non-celiac wheat sensitivity instead of NCGS
(Carroccio, Rini, & Mansueto, 2014).
The patented method used in this study for the assessment of
CXCL10 secretion by the PBMCs of NCGS patients was deemed a
possible biochemical test to help in the diagnosis of this disease.
The responses of NCGS patients enrolled in this study, however,
proved non-homogeneous. In particular, analyzing the differential
secretion of CXCL10 (CXCL10[Manitoba]  CXCL10[Rice]) in NCGS
patients we observed two different groups of patients: the first
(44.7% of enrolled patients) showed differential responses higher
or equal to 80 pg/ml, (threshold value to define positivity in the
patented method) while the second showed differential responses
lower than 80 pg/ml (55.3% of enrolled patients) even though on
average higher compared to healthy controls. Although only a por-
tion of NCGS patients can be defined as positive to this test, the
method sheds light on a possible mechanism involved in theated in NCM-460 cell monolayers 48 h after CXCL10 addition to the basolateral side of
ates statistically significant downregulations.
Ct)
CXCL10 10 ng/ml
P < 0.05 Mean SD P < 0.05
– 0.70 0.06 ⇩
– 0.81 0.07 –
⇩ 0.63 0.06 ⇩
– 1.12 0.11 –
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interesting that even a small percentage of healthy donors (10%)
showed a differential secretion of CXCL10 higher or equal to
80 pg/ml. This suggests that the increased CXCL10 secretion by
PBMC in response to contact with the proteins of gluten-containing
cereals is a physiological mechanism but it tends to increase signif-
icantly in the NCGS population. This finding also indicates that
modern grains are able to induce significantly more CXCL10 secre-
tion by PBMC compared to the ancient grains. This is true both in
healthy controls and in NCGS patients, although the differences in
patients were much more evident in terms of chemokine amount.
CXCL10 is a chemokine produced mainly by neutrophils and
macrophages but also by resident cells such as endothelial cells,
able to recruit leukocytes (Ahmadi, Arababadi, & Hassanshahi,
2013). CXCL10 has been found overexpressed in colonic mucosa
during active irritable bowel syndrome (IBS) (Ostvik et al., 2013),
in the duodenal mucosa of untreated CD patients (Bondar et al.,
2014), but also in various autoimmune diseases (Ahmadi et al.,
2013) suggesting its active role in triggering tissue inflammation.
Its over-expression in PBMC from NCGS patients, after wheat pro-
tein contact, if it happened also in vivo following wheat ingestion,
could explain the peculiar distribution of IEL observed in NCGS
duodenal biopsies (Villanacci, Lanzini, Lanzarotto, & Ricci, 2013).
We analyzed the in vitro response of PBMC from 13 CD patients
(of whom 8 on a gluten-free diet) to wheat protein, in terms of
CXCL10 secretion. CD patients with active disease showed more
than fivefold higher secretions of CXCL10 with respect to NCGS
patients, while treated CD patients on a gluten-free diet showed
a similar behavior to that of healthy controls (see Supplementary
Fig. 1). Our data indicate that the chemokine CXCL10 actually con-
tributed to the loss of intestinal epithelial barrier function associ-
ated with inflammation. Indeed, CXCL10 in the basolateral
compartment of epithelial monolayers is also able to change TEER
by decreasing both CDH1 and TJP2 mRNA expression. This may
reduce tight junction strands, strand alterations and breaks (Lu
et al., 2013). In the presence of increased intestinal permeability,
undigested or partially digested wheat proteins could easily reach
the immune cells in the intestinal wall and induce them to increase
CXCL10 secretion on the serosal side, creating a sort of loop which
tends to maintain the decreased intestinal permeability. Sapone
et al. (2011) hypothesized the existence of decreased permeability
in the intestine of NCGS patients. However, the indirect methods
used and the overlap of intestinal disorders in NCGS and IBS
patients, characterized instead by an increased intestinal perme-
ability, shed some doubt on the existence of a decreased intestinal
permeability in NCGS patients (Vazquez-Roque et al., 2013).
5. Conclusion
This study highlights a new wheat protein-induced mechanism
triggering increased CXCL10 secretion in NCGS patients. For the
first time, we stress that wheat proteins trigger pro-inflammatory
mechanisms in a manner dependent on the wheat variety, but
independent of both gluten content and gluten allergenic epitopes,
as they are currently known. In other words, it is reasonable to
assume that other hitherto unknown pro-inflammatory character-
istics of wheat proteins exist and are much more prominent in the
protein extracts of modern dwarf varieties, if compared to ancient
wheat genotypes.
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